Brief: DSM-Firmenich Q2 Adj. EBITDA At EUR 466 Mln
BRIEF-DSM-Firmenich Q2 Adj. EBITDA At EUR 466 Mln July 30 (Reuters) - DSM-Firmenich AG DSFIR.AS:
ADJUSTED EBITDA MARGIN IMPROVED SEQUENTIALLY, WITH POSITIVE MOMENTUM INTO SECOND HALF
Q2 ADJUSTED. EBITDA AT EUR 466 MILLION
Q2 SALES AT EUR 2,388 MILLION
WE ACHIEVED GOOD VOLUME-LED LFL GROWTH IN FIRST SIX MONTHS OF YEAR ACROSS ALL BUSINESSES
PERFUMERY & BEAUTY DELIVERED A LFL SALES GROWTH OF 7%, FULLY VOLUME DRIVEN, ON A CONTINUED GOOD BUSINESS MOMENTUM WITH STRONG MONTH OF JUNE
FINE FRAGRANCES AS WELL AS CONSUMER FRAGRANCES DELIVERED DOUBLE-DIGIT LFL GROWTH FROM STRONG MARKET DEMAND
Further company coverage: DSFIR.AS
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on DSM-Firmenich AG
See all newsAnalysis: Brazil's corn ethanol boom accelerating growth of feedlot beef
Top of the Street: Hensoldt, Unilever, Evonik, dsm-firmenich, IMCD, AAK
Weak US sentiment hurts dietary supplement sales, offsetting broader growth, Novonesis CEO says
Europe Research Roundup: Asos, Erste Group, SCHOTT pharma
Dsm-firmenich raises growth outlook in line with expectations (updated)